JPRN-UMIN000017785已完成未知
A study of irbesartan/amlodipine on hypertensive patients - AIMIX study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy to Irbesartan/Amloipine 2) Renal aretery stenosis of one or both sides 3) Severe liver dysfunction 4) Alcoholic or drug abuse 5) Pregnancy or nursing 6) Myocardial and cerebral infarction in three months 7) Blood tests are as follows. a) AST or ALT more than 2.5 folds or equal to standard values b) Total bilirubin more than or equal to 3.0 mg/dL c) Serum creatinine more than or equal to 2.5 mg/dL d) Serum potassium more than or equal to 5.0 mEq/L 8) Other inappropiate patients
研究者
相似试验
进行中（未招募）
1 期
Irbesartan in the treatment of Hypertensive Patients with Metabolic Syndrome.Irbesartan en el tratamiento del paciente hipertenso con síndrome metabólicoHypertension, nosEUCTR2005-000614-12-ESBristol Myers Squibb International Corporation540
进行中（未招募）
不适用
Irbesartan in the treatment of Hypertensive Patients with Metabolic Syndrome.Revised Protocol 2, incorporating Protocol Amendments 01 dated 09-Jan-06 & 02 dated 05-Oct-2006. And Protocol amendment 03 dated 24-Oct-2006 - Biomarkers Substudy.EUCTR2005-000614-12-DEBristol Myers Squibb International Corporation540
进行中（未招募）
不适用
Irbesartan in the treatment of Hypertensive Patients with Metabolic Syndrome.Treatment of hypertensive patients with metabolic syndromeMedDRA version: 6.1Level: HLGTClassification code 10057166EUCTR2005-000614-12-ITBRISTOL-M.SQUIBB540
已完成
3 期
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg MonotherapyHypertensionNCT00957554Sanofi435
已完成
3 期
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg MonotherapyHypertensionNCT00956644Sanofi406